Open main menu
Search Ctrl + K
Free Trial
Loading...
Gilead Sciences, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.GILD
333 Lakeside Dr, Foster City, CA, 94404
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Prospectuses and Registrations
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
15 Nov 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
13 Nov 24
FWP
Free Writing Prospectuses - Filing Under Securities Act Rules 163/433.
13 Nov 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
22 Mar 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
20 Mar 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
15 Mar 24
SC TO-T/A
Amended Tender Offer Statement By Third Party.
11 Mar 24
News
8-K
Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Other Events, Financial Statements And Exhibits
20 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
17 Jul 24
8-K
Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
09 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
25 Apr 24
8-K
Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
22 Mar 24
Ownership
4
Mercier Johanna
07 Nov 24
4
Parsey Merdad
07 Nov 24
144
Johanna Mercier
06 Nov 24
144
Merdad V Parsey
06 Nov 24
4
Telman Deborah H
28 Oct 24
4
Parsey Merdad
02 Oct 24
144
Merdad V Parsey
01 Oct 24
Financials
10-Q
Quarterly Filing
12 Nov 24
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
08 May 24
10-Q
Quarterly Filing
07 Nov 23
10-Q
Quarterly Filing
04 Aug 23
10-Q
Quarterly Filing
03 May 23
10-K
Fiscal Year 2022
22 Feb 23
Other
UPLOAD
Letter From The Sec.
05 May 23
CORRESP
Correspondence With The Sec.
25 Apr 23
UPLOAD
Letter From The Sec.
29 Mar 23
CT ORDER
Confidential Treatment Order By The Sec.
02 Feb 22
CORRESP
Correspondence With The Sec.
02 Oct 20
CT ORDER
Confidential Treatment Order By The Sec.
14 Apr 20
CT ORDER
Confidential Treatment Order By The Sec.
14 Apr 20
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Mar 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Mar 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
18 Mar 24
PX14A6G
Notice Of Exempt Solicitation Under Rule 14a-2(b)(1).
06 Apr 23
DEFR14A
Definitive Revised Proxy Soliciting Materials (revised Material).
05 Apr 23
PX14A6G
Notice Of Exempt Solicitation Under Rule 14a-2(b)(1).
29 Mar 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
23 Mar 23